Mo Chen, PhD, is a clinical scientist in the neuroscience research program. He joined Gillette in 2021, when he saw the opportunity to bring nearly 10 years of research knowledge and experience to a clinical setting, where what he learned would more directly translate to improvements in patient care. His research at Gillette focuses on exploring the potential to use non-invasive neuromodulation techniques to enhance or suppress neuron activities in order to improve motor functions and reduce spasticity in patients with cerebral palsy. He also tries to use neuromodulation techniques as a probe to reveal biomarkers of disorders in order to provide scientific feedback and advice to both providers and patients to assist them in making better care decisions.